Newswire (Published: Tuesday, December 12, 2017, Received: Thursday, December 7, 2017, 11:22:52 PM CST)

Word Count: 524

Findings from Department of Medicine Update Knowledge of Prostate Cancer (Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer)

By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on Oncology - Prostate Cancer are presented in a new report. According to news reporting out of Washington, District of Columbia, by NewsRx editors, research stated, "To assess physicians' attitudes regarding multiple factors that may influence recommendations for active surveillance (AS) vs active treatment (AT) given the central role physicians play in the treatment decision-making process. We conducted semistructured interviews to assess factors that physicians consider important when recommending AS vs AT, as well as physicians' perceptions of what their patients consider important in the decision."

Our news journalists obtained a quote from the research from the Department of Medicine, "Participants included urologists (N = 11), radiation oncologists (N = 12), and primary care physicians (N = 10) from both integrated and fee-for-service healthcare settings. Across the specialties, quantitative data indicated that most physicians reported that their recommendations for AS were influenced by patients' older age, willingness and ability to follow a surveillance protocol, anxiety, comorbidities, life expectancy, and treatment preferences. Qualitative findings highlighted physicians' concerns about malpractice lawsuits, given the possibility of disease progression. Additionally, most physicians noted the role of the healthcare setting, suggesting that financial incentives may be associated with AT recommendations in fee-for-service settings. Finally, most physicians reported spouse or family opposition to AS due to their own anxiety or lack of understanding of AS. We found that patient and physician preferences, healthcare setting, and family or spouse factors influence physicians' treatment recommendations for men with low-risk PCa."

According to the news editors, the research concluded: "These were consistent themes across physician subspecialties in both an Health Maintenance Organization and in fee-for-service settings."

For more information on this research see: Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer. Urology, 2017;107():86-94. Urology can be contacted at: Elsevier Science Inc, 360 Park Ave South, New York, NY 10010-1710, USA. (Elsevier -; Urology -

Our news journalists report that additional information may be obtained by contacting K. Davis, MedStar Georgetown Univ Hosp Center, Dept. of Med, Washington, DC, United States. Additional authors for this research include P. Bellini, C. Hagerman, R. Zinar, D. Leigh, R. Hoffman, D. Aaronson, S. Van den Eeden, G. Philips and K. Taylor (see also Oncology - Prostate Cancer).

The direct object identifier (DOI) for that additional information is: This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Keywords for this news article include: Washington, District of Columbia, United States, North and Central America, Cancer, Epidemiology, Prostatic Neoplasms, Prostate Cancer, Legal Issues, Oncology, Department of Medicine.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC


Central America
North America
United States
District of Columbia
New York
New York City


Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
            Urological Diseases
      Medical Specialties and Practices